- Home
- Results news
- Trident Texofab
- Q2 FY27 results
Trident Texofab Q2 FY27 results: net profit down 46.9% to ₹0.60 crore, revenue down 17.3%
Trident Texofab Limited reported standalone revenue of ₹25.34 crore for Q2 FY27, down 17.3% from ₹30.63 crore a year earlier, while net profit fell 46.9% to ₹0.60 crore from ₹1.13 crore. EBITDA was ₹0.90 crore with a margin of 3.5%, against 8.1% in Q2 FY26, though profit was higher than the previous quarter and basic EPS rose to ₹0.80 from ₹0.35 in Q1 FY27. The figures are standalone, as approved by the board on 5 November 2026.
Key points
- Q2 FY27 revenue fell 17.3% to ₹25.34 crore from ₹30.63 crore in Q2 FY26
- Net profit fell 46.9% to ₹0.60 crore from ₹1.13 crore a year earlier
- EBITDA of ₹0.90 crore carried a margin of 3.5%, down 4.6 percentage points
- Profit before tax was ₹0.89 crore, up 29.0% from ₹0.69 crore in Q1 FY27
- Basic EPS was ₹0.80, up from ₹0.35 in the previous quarter and ₹0.77 a year earlier
- H1 FY27 revenue of ₹51.48 crore was down 12.3% from ₹58.71 crore in H1 FY26
How did Trident Texofab perform in Q2 FY27?
Trident Texofab's standalone revenue for the July–September 2026 quarter was ₹25.34 crore, down 17.3% from ₹30.63 crore in Q2 FY26 and down 3.1% from ₹26.14 crore in Q1 FY27. Total income fell 13.5% year on year to ₹26.83 crore from ₹31.03 crore, while other income of ₹1.50 crore was higher than the ₹0.39 crore reported a year earlier. The reported figures are on a standalone basis; no consolidated numbers are given.
EBITDA for the quarter was ₹0.90 crore, down 63.9% from ₹2.49 crore in Q2 FY26, and margin was 3.5% against 8.1%, a fall of 4.6 percentage points. Against Q1 FY27, EBITDA fell 37.1% from ₹1.43 crore and margin was lower by 2.0 percentage points from 5.5%. Profit before tax was ₹0.89 crore, down 41.1% year on year from ₹1.51 crore but up 29.0% from ₹0.69 crore in the previous quarter.
Net profit for the quarter was ₹0.60 crore, down 46.9% from ₹1.13 crore in Q2 FY26 and up 15.4% from ₹0.52 crore in Q1 FY27. The net profit margin was 2.4% against 3.7% a year earlier and 2.0% in the previous quarter. Basic EPS was ₹0.80, up 3.9% from ₹0.77 a year earlier and 128.6% from ₹0.35 in Q1 FY27. Tax expense was ₹0.28 crore, down 26.3% from ₹0.38 crore a year earlier.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 25.34 | 26.14 | 30.63 | −17.3% | −3.1% |
| Other income | 1.50 | 0.19 | 0.39 | +284.6% | +689.5% |
| Total expenses | 25.95 | 25.64 | 29.52 | −12.1% | +1.2% |
| EBITDA | 0.90 | 1.43 | 2.49 | −63.9% | −37.1% |
| EBITDA margin | 3.5% | 5.5% | 8.1% | −4.6 pp | −2.0 pp |
| Profit before tax | 0.89 | 0.69 | 1.51 | −41.1% | +29.0% |
| Tax | 0.28 | 0.17 | 0.38 | −26.3% | +64.7% |
| Net profit | 0.60 | 0.52 | 1.13 | −46.9% | +15.4% |
| EPS (₹) | 0.80 | 0.35 | 0.77 | +3.9% | +128.6% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Trident Texofab's costs and profit?
Total expenses for Q2 FY27 fell 12.1% year on year to ₹25.95 crore from ₹29.52 crore, and were 1.2% higher than the ₹25.64 crore recorded in Q1 FY27. Cost of materials consumed was ₹3.38 crore, down 23.2% from ₹4.40 crore a year earlier, and employee cost was ₹0.63 crore, down 17.1% from ₹0.76 crore.
Finance costs rose to ₹1.12 crore from ₹0.96 crore a year earlier, an increase of 16.7%, and were ₹0.57 crore higher than the ₹0.55 crore in Q1 FY27. Depreciation was ₹0.39 crore against ₹0.41 crore a year earlier, while other expenses fell to ₹0.47 crore from ₹1.08 crore, a decrease of 56.5%.
Other income was ₹1.50 crore, up ₹1.11 crore from ₹0.39 crore a year earlier and up ₹1.31 crore from ₹0.19 crore in the previous quarter. There was no exceptional item in the quarter. Tax expense was ₹0.28 crore, down ₹0.10 crore from ₹0.38 crore a year earlier and up ₹0.11 crore from ₹0.17 crore in Q1 FY27.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 3.38 | 4.40 | −1.02 | −23.2% |
| Employee cost | 0.63 | 0.76 | −0.13 | −17.1% |
| Finance costs | 1.12 | 0.96 | +0.16 | +16.7% |
| Depreciation | 0.39 | 0.41 | −0.02 | −4.9% |
| Other expenses | 0.47 | 1.08 | −0.61 | −56.5% |
| Total expenses | 25.95 | 29.52 | −3.57 | −12.1% |
| Other income | 1.50 | 0.39 | +1.11 | +284.6% |
| Tax | 0.28 | 0.38 | −0.10 | −26.3% |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 51.48 | 58.71 | −12.3% |
| Profit before tax | 1.57 | 2.88 | −45.5% |
| Net profit | 1.13 | 2.14 | −47.2% |
| EPS (₹) | 1.50 | 1.47 | +2.0% |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
Total assets stood at ₹117.38 crore as on 30 September 2026, against ₹111.16 crore as on 31 March 2026, while total equity was ₹56.71 crore compared with ₹55.58 crore. Borrowings rose to ₹41.54 crore from ₹33.60 crore at the previous balance sheet date. Cash and cash equivalents were ₹0.11 crore, against ₹0.06 crore.
Inventories were ₹20.18 crore as on 30 September 2026, against ₹20.57 crore as on 31 March 2026. Trade receivables fell to ₹36.00 crore from ₹48.55 crore, and trade payables were ₹10.02 crore against ₹13.05 crore at the earlier date.
For H1 FY27, net cash used in operating activities was ₹6.55 crore, compared with ₹3.65 crore in H1 FY26. Investing activities generated ₹0.35 crore against a net outflow of ₹1.82 crore a year earlier, and financing activities provided ₹6.24 crore against ₹2.44 crore. Capital expenditure in the half year was ₹0.85 crore.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 117.38 | 111.16 |
| Total equity | 56.71 | 55.58 |
| Borrowings | 41.54 | 33.60 |
| Cash and equivalents | 0.11 | 0.06 |
| Inventories | 20.18 | 20.57 |
| Trade receivables | 36 | 48.55 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | −6.55 | −3.65 |
| Cash from investing | 0.35 | −1.82 |
| Cash from financing | 6.24 | 2.44 |
| Capital expenditure | 0.85 | 0 |
Source: Company's results filing (XBRL).
How has Trident Texofab done over the last 8 quarters?
Revenue peaked at ₹38.21 crore in Q4 FY25 and bottomed at ₹25.34 crore in Q2 FY27, the latest quarter reported. It has been lower for three consecutive quarters after the Q4 FY26 level of ₹33.57 crore, with Q1 FY27 at ₹26.14 crore before easing to ₹25.34 crore.
Profit for the period was lowest at a net loss of ₹2.01 crore in Q4 FY26, when the EBITDA margin was also at its low of -3.2%. The margin has since recovered to 5.5% in Q1 FY27 but eased to 3.5% in Q2 FY27, still below the 8.1% recorded in Q2 FY26.
How did other Other Textile Products companies do?
Ninety-three other companies in the Other Textile Products industry filed for this quarter, with a median revenue growth of 20.8%. Of the peers compared on revenue growth, 78 grew faster than Trident Texofab and 15 grew slower than the company.
Out of 96 peers compared on profit, 69 reported higher profit in the quarter.
| Trident Texofab revenue growth (YoY) | −17.3% |
|---|---|
| Median of 93 other Other Textile Products companies | +20.8% |
| Companies with slower revenue growth than Trident Texofab | 15 of 93 |
| Companies with faster revenue growth than Trident Texofab | 78 of 93 |
| Companies whose net profit rose | 69 of 96 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was Trident Texofab's revenue in Q2 FY27?
Revenue from operations was ₹25.34 crore, down 17.3% from ₹30.63 crore in Q2 FY26 (standalone).
Did Trident Texofab make a profit in Q2 FY27?
Yes. Net profit was ₹0.60 crore, against a net profit of ₹1.13 crore in Q2 FY26.
What was Trident Texofab's EPS in Q2 FY27?
Basic earnings per share were ₹0.80, against ₹0.77 in Q2 FY26.
When did Trident Texofab announce its Q2 FY27 results?
On 5 November 2026, in a filing to the BSE.
Sources
- Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Result For Quarter And Half Year Ended 30.09.2026 (BSE, 31 October 2026) · PDF
- Board Meeting Outcome for Outcome Of Board Meeting Held On 05.11.2026 (BSE, 5 November 2026) · PDF
- Result- Financial Result For The Quarter And Half Year Ended 30.09.2026 (BSE, 5 November 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.